Not Available
Award amount
$99,616Program and phase
SBIR · Phase IAward year
2000Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ViaCyte, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- QKEMQKGYSSL1
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Treatment of type 1 diabetes with human embryonic stem cell derived pancreatic beta-like cells
- Development of human embryonic cell lines
Research funding history
3 SBIR/STTR records share this UEI (2000–2017). Reported award amounts total $1,698,595. Reported amounts are not federal obligations.
Phases: Phase I, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services